$REGN Regeneron, Wait for better entry REGN making some moves in the pre-market, but care needed on rash entries. Multiple resistance factors to cross before risk \ reward improves. 50 & 100ma's 2015 pivot point @ $605by BullishchartsPublished 23
New breakout Looking at long term trends. Old breakout finished with multi year consolidation. New breakout started with all time high. Will this new breakout hold? Longby BiotechkingUpdated 2
Fib fan on latest up trend. Trend broken?Trend slowly moved to 0. Recently broke down below 0. Previous high acting as support 50 day support broken. Few more days to confirm if breakout failed.by BiotechkingUpdated 0
#REGN REGNERON LONG-TERM INVESTMENT From 400$ -> 1400$ !#REGN REGNERON LONG-TERM INVESTMENT From 400$ -> 1400$ !Longby clovers7Published 1
REGN at 50 lines againSold this one for a 3.70% gain after weakness on earnings. The story seems intact. Good risk/reward entry here at 50 days line again. IBD rating 98 RS rating 92 Long @ 620.37.Longby rg_trader_investorPublished 0
REGN projection to 750 analyst targetUsed the pitch fork tool to determine when the current trend would align with the new analyst target of 750. First time using tool. Please provide feedback.Longby BiotechkingUpdated 4
REGN trying to go higherThis seems as a low risk entry here at 50 days, should rebound if the market continues higher after the previous last week pullback The market was showing a reversal for most of Friday. Looking for a continuation on Monday. IBD rating of 98 RS rating 94 Long @ 610.37Longby rg_trader_investorPublished 7
REGN new breakoutBreakout today, seems like it failed at the end of the day, but entire market followed the same pattern at closing. Volume was higher throughout the day on the way higher and lower on the retreat, a good sign IBD perfect rating of 99. Long @ 645.90 Longby rg_trader_investorPublished 2
REGN support resistance channelsIn this chart the channels 1,2,3 are of equal distance. On the week of Feb 24th REGN broke out of the channel 1 and within the next 4 months it proceeded to gain over 50%. It did break out to a new All time high(ATH) as well , and momentarily had broken out into channel 3. This week (06/22) we saw that the perceived support of channel 3 didn't hold. Although I'm playing this short , I'll do so with a great deal of caution. Marked in red is the Bearish idea I'm playing: Since REGN got rejected of the channel 3 is possible that the old time high won't hold as support as well. REGN could then Test the highs of 2017 ( marked by the circles) before potentially testing a possible double resistance ( resistance of old time high and resistance of channel2) In this particular scenario (if it happens ) a short position will be taken and cut losses will happen if REGN breaks above to channel 3 on the weekly chart. Now on the bullish side : If REGN breaks above the $630 perceived resistance of channel 2 it could push higher torwards the $700 mark(marked in green pattern ). It would be nice if it than comes and tests the OLD time high and perceived support of channel 3 , thus making it clear that a long position would be profitable perhaps to $800+ These support and resistance areas change as time progresses. So although $800+ would be resistance at around 09/2021 that same resistance line would be $780 just a year later. So, continue to study the charts and adjust as time moves on. Trade with care and have fun! R.I.P( Research Invest Prosper) Shortby JoeOddlotsPublished 2
Vaccine News ComingRumors brewing on big vaccine news in next week. Might grab some Calls here for shits.. Longby WDERUVEPublished 8
FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed tREGN: Regeneron Pharmaceuticals, Inc. 2020-06-19 13:44:00 FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-AdministrationLongby RocketTickersPublished 6
REGN to see if it can tag the ATH!Hello! Going long REGN at 578.46 with s target of 603.00. Looks like a good SETUP, so please apply your own plan, own targets.Longby VaggitarianUpdated 4
Buy to REGENERON PHARMACEUTICALSHey people, **DISCLAIMER** content on this analysis is subject to change at any time without notice, and is provided for the sole purpose of assisting traders to make independent investment decisions. The buyers' attempt forcefully rejected, the sellers can regain control. Please LIKE & FOLLOW, thank you!Shortby stephanelibatdPublished 4
Look at that Volume!!What I see... + Ultra high volume to a strong closing day + Prices pulled back to find support from the 50ma and today returned to close above the 10ma + Prices stop short of the Fib. + RSI has just turned upward at 57 - MACD is below the signal line - Upper shadow - Resistance at all time high What I setup... + Long entry when break above the Resistance - Stop under today's low + Target is at 1.618 Fib :: Duration - ~4 weeks maybe? ** Likes and Comments are appreciated; New Subscribers are Insightful! **Longby ShakeShakeLegUpdated 5
REGN: Reached the wave (iii) target of 1.618 Extension.However, the RSI and MACD do not show overbought condition. It has more room to hit the top of the channel. Also, an iHnS pattern shows a potential target in line with fib 1.887 extension of wave (i).Longby Will_WongPublished 5
$REGN:NASDAQ - REGENERON PHARMACEUTICALSRegeneron has been having a nice run since the end of last year and is up around 100%. Financials look pretty strong. Could be worth a watch. Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. Longby zAngusUpdated 3
Growth Channel and Strong support lineEntry Price- 563.3 TP1 - 567.64 +0.77% TP2 - 573.79 +1.86% TP3 - 578.58 +2.71% SL - 557.33 -1.06%Longby SerSegaPublished 3